We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

239 hedge funds and large institutions have $1.24B invested in Pacira BioSciences in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 95 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

374% more call options, than puts

Call options by funds: $3.13M | Put options by funds: $661K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

23% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 30

3% more funds holding

Funds holding: 233 → 239 (+6)

2% more capital invested

Capital invested by funds: $1.21B → $1.24B (+$28.4M)

2.41% less ownership

Funds ownership: 109.17% → 106.76% (-2.4%)

29% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 95

Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
67
Reduced
95
Closed
30
Calls
$3.13M
Puts
$661K
Net Calls
+$2.47M
Net Calls Change
-$2.36M

Top Buyers

1
DPCM
Doma Perpetual Capital Management
Florida
+$22M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.1M
3
American Century Companies
American Century Companies
Missouri
+$4.81M
4
Morgan Stanley
Morgan Stanley
New York
+$4.73M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.16M

Top Sellers

1
PCH
Polar Capital Holdings
United Kingdom
-$21.8M
2
BlackRock
BlackRock
New York
-$11.3M
3
EC
EcoR1 Capital
California
-$10.9M
4
Millennium Management
Millennium Management
New York
-$10.9M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$8.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
176
Nisa Investment Advisors
Missouri
$59.1K +$1.92K +78 +4%
T
177
Tidemark
California
$55.9K +$53.3K +2,169 New
Rockefeller Capital Management
178
Rockefeller Capital Management
New York
$48.2K +$46K +1,871 New
Canada Pension Plan Investment Board
179
Canada Pension Plan Investment Board
Ontario, Canada
$46.4K -$17.2K -700 -28%
Mirae Asset Global Investments
180
Mirae Asset Global Investments
South Korea
$44.8K -$1.28K -52 -3%
Acadian Asset Management
181
Acadian Asset Management
Massachusetts
$35K -$369K -15,028 -92%
US Bancorp
182
US Bancorp
Minnesota
$29.5K -$23.2K -944 -45%
HFS
183
Hantz Financial Services
Michigan
$29K +$17.7K +721 +175%
VCM
184
Versant Capital Management
Arizona
$27.6K -$2.65K -108 -9%
SAM
185
Shell Asset Management
Netherlands
$26K -$19K -772 -43%
1IA
186
1620 Investment Advisors
Massachusetts
$25.2K – – –
GFM
187
GF Fund Management
China
$24.9K -$5.28K -215 -18%
FFL
188
Financial Freedom LLC
Ohio
$22.3K – – –
Fifth Third Bancorp
189
Fifth Third Bancorp
Ohio
$20.6K -$7.07K -288 -26%
ITIM
190
Indiana Trust & Investment Management
Indiana
$19.6K – – –
IA
191
IFP Advisors
Florida
$17.3K +$5.5K +224 +50%
ATC
192
Adirondack Trust Company
New York
$15.5K – – –
SAM
193
Smartleaf Asset Management
Massachusetts
$14.7K +$10.1K +410 +243%
QCG
194
Quadrant Capital Group
Ohio
$14.3K +$13.6K +555 New
PFBT
195
Parkside Financial Bank & Trust
Missouri
$13.4K +$589 +24 +5%
CPG
196
Cornerstone Planning Group
New Jersey
$12K +$1.06K +43 +239%
BNP Paribas Asset Management
197
BNP Paribas Asset Management
France
$11K – – –
C
198
Covestor
United Kingdom
$10K -$958 -39 -9%
Bessemer Group
199
Bessemer Group
New Jersey
$10K +$688 +28 +8%
EWA
200
EverSource Wealth Advisors
Alabama
$9.48K -$11.9K -485 -57%
6 7
8
9 10

PCRX Hedge Fund Activity: Q3 2025 in Review

239 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2025, worth a combined $1.24B — up 2.3% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCRX positions and 30 closed out — a net gain of 7 holders — while 67 added to existing stakes and 95 trimmed.

The largest buyer was Doma Perpetual Capital Management, adding an estimated $22M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $21.8M sold.

  • 239 institutional investors held Pacira BioSciences (PCRX) as of Q3 2025, up from 233 in Q2 2025.
  • Funds reported $1.24B of Pacira BioSciences stock for Q3 2025, up 2.3% quarter-over-quarter.
  • 37 funds opened new Pacira BioSciences positions in Q3 2025 and 30 closed out, a net change of +7 holders.
  • The largest Pacira BioSciences buyer in Q3 2025 was Doma Perpetual Capital Management, an estimated $22M added.
  • The largest Pacira BioSciences seller in Q3 2025 was Polar Capital Holdings, an estimated $21.8M sold.

Based on aggregated 13F filings for Q3 2025.